ASP9521, a novel, selective, orally bioavailable AKR1C3 (type 5, 17β-hydroxysteroid dehydrogenase) inhibitor: In vitro and in vivo characterization.

被引：0
|
作者：
Kikuchi, Aya
Enjo, Kentaro
Furutani, Takashi
Azami, Hidenori
Nimi, Tatsuya
Kuromitsu, Sadao
Kamiyma, Yoshiteru
机构：
[1] Astellas Pharma US Inc, Ibaraki, Japan
[2] Astellas Pharma US Inc, Deerfield, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Characterization of the major single nucleotide polymorphic variants of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase)
    Detlefsen, Andrea J.
    Wangtrakuldee, Phumvadee
    Penning, Trevor M.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2022, 221
  • [32] Eliminating the androgen signal by human type 3 3α-hydroxysteroid dehydrogenase (AKR1C2):: structural and kinetic analyses on the reduction of 5α-dihydrotestosterone
    Jin, Y
    Heredia, V
    Penning, T
    FASEB JOURNAL, 2005, 19 (04): : A304 - A304
  • [33] STX2171, a 17β-Hydroxysteroid Dehydrogenase Type 3 (17β-HSD3) Inhibitor, Is Efficacious In Vivo in a Novel Hormone-Dependent Prostate Cancer Model.
    Day, J. M.
    Foster, P. A.
    Tutill, H. J.
    Hargrave, J. D.
    Schmidlin, F.
    Vicker, N.
    Potter, B. V. L.
    Reed, M. J.
    Purohit, A.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [34] Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol
    Verica Milivojevic
    Richard Feinn
    Henry R. Kranzler
    Jonathan Covault
    Psychopharmacology, 2014, 231 : 3597 - 3608
  • [35] Type 5 17-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3) inhibition and potential anti-proliferative activity of cholest-4-ene-3,6-dione in MCF-7 breast cancer cells
    Sali, Veeresh Kumar
    Mani, Sugumar
    Meenaloshani, G.
    Ilavarasi, Anbumani Velmurugan
    Vasanthi, Hannah R.
    STEROIDS, 2020, 159
  • [36] Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol
    Milivojevic, Verica
    Feinn, Richard
    Kranzler, Henry R.
    Covault, Jonathan
    PSYCHOPHARMACOLOGY, 2014, 231 (17) : 3597 - 3608
  • [37] Enzymatic mechanism of 5α-dihydrotestosterone reduction catalyzed by human type 3 3α-hydroxysteroid dehydrogenase (AKR1C2):: Molecular docking and kinetic studies
    Jin, Y
    Heredia, VV
    Penning, TM
    Enzymology and Molecular Biology of Carbonyl Metabolism 12, 2006, 12 : 294 - 300
  • [38] Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models
    Kenmogne, Lucie Carolle
    Roy, Jenny
    Maltais, Rene
    Rouleau, Melanie
    Neveu, Bertrand
    Pouliot, Frederic
    Poirier, Donald
    PLOS ONE, 2017, 12 (02):
  • [39] Discovery of a Potent, Selective, and Orally Bioavailable Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor: Discovery of 2-[(3S)-1[5-(Cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic Acid (AZD4017)
    Scott, James S.
    Bowker, Suzanne S.
    deschoolmeester, Joanne
    Gerhardt, Stefan
    Hargreaves, David
    Kilgour, Elaine
    Lloyd, Adele
    Mayers, Rachel M.
    McCoull, William
    Newcombe, Nicholas J.
    Ogg, Derek
    Packer, Martin J.
    Rees, Amanda
    Revill, John
    Schofield, Paul
    Selmi, Nidhal
    Swales, John G.
    Whittamore, Paul R. O.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (12) : 5951 - 5964
  • [40] SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
    Strizki, JM
    Xu, S
    Wagner, NE
    Wojcik, L
    Liu, J
    Hou, Y
    Endres, M
    Palani, A
    Shapiro, S
    Clader, JW
    Greenlee, WJ
    Tagat, JR
    McCombie, S
    Cox, K
    Fawzi, AB
    Chou, CC
    Pugliese-Sivo, C
    Davies, L
    Moreno, ME
    Ho, DD
    Trkola, A
    Stoddart, CA
    Moore, JP
    Reyes, GR
    Baroudy, BM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) : 12718 - 12723
12345